Living with Alzheimer’s-Related Agitation?
Explore Agitation in Alzheimer’s Clinical Trials in Michigan
Alzheimer’s disease is a progressive neurological condition that affects memory, thinking, and behavior. In addition to cognitive decline, many individuals experience agitation, which may include restlessness, irritability, emotional distress, or aggressive behaviors. These symptoms can be difficult for patients and place significant emotional and physical strain on caregivers.
Agitation is a common but often under-recognized symptom of Alzheimer’s disease. When left unmanaged, it can interfere with daily routines, disrupt sleep, and reduce overall quality of life.
It may also increase emotional distress for both patients and caregivers, making everyday interactions more challenging.
Revival Research Institute is conducting Alzheimer’s clinical trials to evaluate an investigational treatment that may potentially reduce agitation in Alzheimer’s patients. These Alzheimer’s research studies are designed to explore safe and effective approaches to managing agitation while advancing future treatment options.
Are You Eligible to Participate?
To participate in our Alzheimer’s disease clinical trials in Michigan, individuals must meet the following criteria:
- Male & female, 50 years of age or older
- Has a diagnosis of dementia
- Has onset of agitation symptoms at least 2 weeks prior to Visit 1
*Additional criteria may apply.
Participation in Alzheimer’s disease clinical trials in Michigan or other locations provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

